Skin Rash Treatment Market, By Treatment Type, By Skin Rash Type (Contact Dermatitis, Atopic Dermatitis, Psoriasis, Seborrheic Dermatitis, and Others), By Distribution Channel, By Geography .

PUBLISHED: February 27, 2024

PAGES: 155 Pages

DELIVERY TIME: 2-3 business days

ADD TO COMPARE

SELECT AN OPTION

Description

The skin rash treatment market is estimated to be valued at USD 3.67 Bn in 2024 and is expected to reach USD 5.70 Bn by 2031, growing at a compound annual growth rate (CAGR) of 6.5% from 2024 to 2031.

Report Coverage		Report Details
Base Year:	2023	Market Size in 2023/2024:	US$ 3.67 Bn
Historical Data for:	2019 to 2023	Forecast Period:	2024 to 2031
Forecast Period 2023/2024 to 2030/2031 CAGR:	6.50%	2030/2031 Value Projection:	US$ 5.70 Bn

Skin Rash Treatment Market Share (%), By Region, 2024

Skin rashes affect people of all age groups and can occur due to various reasons such as allergies, infections, change in climate etc. Skin rashes cause severe itching, redness and inflammation on the skin. The skin rash treatment market offers a wide range of products such as topical corticosteroids, antihistamines, antimicrobials etc to provide relief from the symptoms. Topical treatments are considered first line therapy for mild to moderate rashes while oral medications may be required for severe cases. With increasing pollution, changing lifestyle and stressful environment prevalent today, the occurrences of skin rashes have been on the rise globally. This has significantly contributed to the growth of the skin rash treatment market over the past decade.

Market Dynamics:

The skin rash treatment market growth is driven by growing product innovation led by increased research and development activities. Companies are developing advanced formulations containing probiotics, amino acids and hyaluronic acid to facilitate faster skin regeneration. Furthermore, rising awareness about preventive healthcare and availability of effective over-the-counter products is also contributing to the market growth. Consumer preference for natural and herbal formulations to treat mild to moderate rashes is surging the demand for aloe vera, calendula, and tea tree based products. Rising environmental pollution levels, changing lifestyles, and exposure to various allergens have significantly contributed to the increasing incidence of skin allergies. As a result, the demand for effective skin rash treatment products such as medicated creams, lotions, sprays, and oral antihistamines has witnessed a considerable surge in the recent past.

Key Features of the Study:

This report provides an in-depth analysis of the global skin rash treatment market, and provides market size (US$ Billion) and Compound Annual Growth Rate (CAGR %) for the forecast period (2024-2031), considering 2023 as the base year
It elucidates potential revenue growth opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global skin rash treatment market based on the following parameters such as company highlights, products portfolio, key highlights, financial performance, and strategies
The key companies covered as a part of this study include CooperSurgical Inc., MEDGYN PRODUCTS INC., Sklar Surgical Instruments, Panpac Medical Corp., Medline Industries LP., Medicem Inc., Hologic Inc., Laborie, Minerva Health Solutions Inc., Marina Medical Inc., Cook Medical, Vernacare, Teleflex Incorporated, Thomas Medical, Surtex Instruments Limited
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
The global skin rash treatment market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global skin rash treatment market

Detailed Segmentation:

By Treatment Type:
- Corticosteroids
- Immunosuppressants
- Antihistamines
- Antifungals
- Others
By Skin Rash Type:
- Contact Dermatitis
- Atopic Dermatitis
- Psoriasis
- Seborrheic Dermatitis
- Others
By Distribution Channel:
- Pharmacies
- Retail Stores
- Others (Hypermarkets, etc.)
By Region:
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East
- Africa
Company Profiles:
- AbbVie
- Amgen
- Bristol Myers Squibb
- Galderma
- Johnson & Johnson
- LEO Pharma
- Merck & Co. Inc.
- Novartis AG
- Pfizer Inc.
- Sanofi
- Sun Pharmaceutical Industries Pvt. Ltd.
- Teva Pharmaceutical Industries
- Valeant Pharmaceuticals
- Mylan N.V.
- Perrigo Company plc
- Eli Lilly and Company
- Bayer AG

Product Code: CMI6688

1. Research Objectives and Assumptions

Research Objectives
Assumptions

2. Market Overview

Report Description
- Market Definition and Scope
Executive Summary
- Market Snapshot By Treatment Type
- Market Snapshot By Skin Rash Type
- Market Snapshot By Distribution Channel
- Market Snapshot By Region
- Market Scenario - Conservative, Like, Opportunistic
- Market Opportunity Map

3. Market Dynamics

Market Dynamics
- Drivers
- Restraints
- Opportunities
Impact Analysis
Pest Analysis
Porters Analysis
Technological Advancement
Merger, Acquisition and Collaboration Scenario
Recent Product Approvals

4. Global Skin Rash Treatment Market, By Treatment Type, 2019 - 2031 (US$ Billion)

Introduction
- Market Size and Forecast, 2019 - 2031, (US$ Billion)
- Segment Trends
Corticosteroids, 2019 - 2031 (US$ Billion)
- Introduction
- Market Size and Forecast, 2019 - 2031, (US$ Billion)
Immunosuppressants, 2019 - 2031 (US$ Billion)
- Introduction
- Market Size and Forecast, 2019 - 2031, (US$ Billion)
Antihistamines, 2019 - 2031 (US$ Billion)
- Introduction
- Market Size and Forecast, 2019 - 2031, (US$ Billion)
Antifungals, 2019 - 2031 (US$ Billion)
- Introduction
- Market Size and Forecast, 2019 - 2031, (US$ Billion)
Others (Antibiotics, etc.), 2019 - 2031 (US$ Billion)
- Introduction
- Market Size and Forecast, 2019 - 2031, (US$ Billion)

5. Global Skin Rash Treatment Market, By Skin Rash Type, 2019 - 2031 (US$ Billion)

Introduction
- Market Size and Forecast, 2019 - 2031, (US$ Billion)
- Segment Trends
Contact Dermatitis, 2019 - 2031 (US$ Billion)
- Introduction
- Market Size and Forecast, 2019 - 2031, (US$ Billion)
Atopic Dermatitis (Eczema), 2019 - 2031 (US$ Billion)
- Introduction
- Market Size and Forecast, 2019 - 2031, (US$ Billion)
Psoriasis, 2019 - 2031 (US$ Billion)
- Introduction
- Market Size and Forecast, 2019 - 2031, (US$ Billion)
Seborrheic Dermatitis, 2019 - 2031 (US$ Billion)
- Introduction
- Market Size and Forecast, 2019 - 2031, (US$ Billion)
Others (Allergic Reactions, etc.), 2019 - 2031 (US$ Billion)
- Introduction
- Market Size and Forecast, 2019 - 2031, (US$ Billion)

6. Global Skin Rash Treatment Market, By Distribution Channel, 2019 - 2031 (US$ Billion)

Introduction
- Market Size and Forecast, 2019 - 2031, (US$ Billion)
- Segment Trends
Pharmacies, 2019 - 2031 (US$ Billion)
- Introduction
- Market Size and Forecast, 2019 - 2031, (US$ Billion)
Retail Stores, 2019 - 2031 (US$ Billion)
- Introduction
- Market Size and Forecast, 2019 - 2031, (US$ Billion)
Others (Hypermarkets, etc.), 2019 - 2031 (US$ Billion)
- Introduction
- Market Size and Forecast, 2019 - 2031, (US$ Billion)

7. Global Skin Rash Treatment Market, By Region, 2019 - 2031 (US$ Billion)

Introduction
- Market Share Analysis, 2024 - 2031, (US$ Billion)
- Segment Trends
- By Region
North America
- Introduction
- Market Size and Forecast, By Treatment Type, 2019 - 2031, (US$ Billion)
- Market Size and Forecast, By Skin Rash Type, 2019 - 2031, (US$ Billion)
- Market Size and Forecast, By Distribution Channel, 2019 - 2031, (US$ Billion)
- Market Size and Forecast, By Country, 2019 - 2031, (US$ Billion)
U.S.
Canada
Europe
- Introduction
- Market Size and Forecast, By Treatment Type, 2019 - 2031, (US$ Billion)
- Market Size and Forecast, By Skin Rash Type, 2019 - 2031, (US$ Billion)
- Market Size and Forecast, By Distribution Channel, 2019 - 2031, (US$ Billion)
- Market Size and Forecast, By Country, 2019 - 2031, (US$ Billion)
U.K.
Germany
Italy
France
Spain
Russia
Rest Of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, By Treatment Type, 2019 - 2031, (US$ Billion)
- Market Size and Forecast, By Skin Rash Type, 2019 - 2031, (US$ Billion)
- Market Size and Forecast, By Distribution Channel, 2019 - 2031, (US$ Billion)
- Market Size and Forecast, By Country, 2019 - 2031, (US$ Billion)
China
India
Japan
Australia
South Korea
Asean
Rest Of Asia Pacific
Latin America
- Introduction
- Market Size and Forecast, By Treatment Type, 2019 - 2031, (US$ Billion)
- Market Size and Forecast, By Skin Rash Type, 2019 - 2031, (US$ Billion)
- Market Size and Forecast, By Distribution Channel, 2019 - 2031, (US$ Billion)
- Market Size and Forecast, By Country, 2019 - 2031, (US$ Billion)
Brazil
Mexico
Argentina
Middle East
- Introduction
- Market Size and Forecast, By Treatment Type, 2019 - 2031, (US$ Billion)
- Market Size and Forecast, By Skin Rash Type, 2019 - 2031, (US$ Billion)
- Market Size and Forecast, By Distribution Channel, 2019 - 2031, (US$ Billion)
- Market Size and Forecast, By Country, 2019 - 2031, (US$ Billion)
GCC
Israel
Rest Of The Middle East
Africa
- Introduction
- Market Size and Forecast, By Treatment Type, 2019 - 2031, (US$ Billion)
- Market Size and Forecast, By Skin Rash Type, 2019 - 2031, (US$ Billion)
- Market Size and Forecast, By Distribution Channel, 2019 - 2031, (US$ Billion)
- Market Size and Forecast, By Country/Region, 2019 - 2031, (US$ Billion)

South Africa
North Africa
Central Africa

8. Company Profiles - Global Skin Rash Treatment Market

AbbVie*
- Company Overview
- Product/Service Portfolio
- Financial Performance
- Recent Developments/Updates
- Strategic Overview
Amgen
Bristol Myers Squibb
Galderma
Johnson & Johnson
LEO Pharma
Merck & Co. Inc.
Novartis AG
Pfizer Inc.
Sanofi
Sun Pharmaceutical Industries Pvt. Ltd.
Teva Pharmaceutical Industries
Valeant Pharmaceuticals
Mylan N.V.
Perrigo Company plc
Eli Lilly and Company